Skip to main content
. 2020 Oct 6;19:175. doi: 10.1186/s12939-020-01285-2

Table 2.

Differential impact of the Quebec Alzheimer Plan for men and women with neurocognitive disorders

Mean Difference
(95% Confidence Interval)
Intercept

52.95

(32.77, 73.12)

Mena

0.04

(−3.49, 3.57)

Post-QAPb,c

4.59

(0.72, 8.46)

Men*Post-QAP

4.97

(0.08, 9.85)

Age

−0.05

(−0.28, 0.18)

Number of Medications

−0.03

(− 0.21, 0.14)

aReference category is women

bReference category is pre-QAP

cQAP Quebec Alzheimer Plan